Reticulocyte Enrichment and Culturing

Total Page:16

File Type:pdf, Size:1020Kb

Reticulocyte Enrichment and Culturing ERYTHROCYTE BIOLOGY AND ITS IMPACT ON PLASMODIUM VIVAX INVASION By EMILY SCHEETZ Submitted in Partial Fulfillment of the Requirements for the degree of Master of Science Department of Pathology CASE WESTERN RESERVE UNIVERSITY August, 2008 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Emily Scheetz candidate for the Master’s degree *. (signed) Mark Smith (chair of the committee) Chris King Clive Hamlin Peter Zimmerman (date) 7-8-2008 *We also certify that written approval has been obtained for any proprietary material contained therein. 1 TABLE OF CONTENTS LIST OF FIGURES………………………………………… 3 Abstract……………………………………………………... 4 Introduction…………………………………………………. 5 Chapter 1- Interaction of Malaria Parasites with human erythrocytes………………………………………………… 5 Erythrocyte Structural Proteins……………………. 5 Assembly of the Erythrocyte………………………. 8 Duffy Expression…………………………………… 10 Genetic Abnormalities of Erythrocytes…………… 16 Chapter 2- Erythrocyte Maturation……………………… 19 Chapter 3- Experimental Support……………………….. 22 Methods……………………………………………... 25 Results………………………………………………. 28 Discussion…………………………………………... 34 Future Directions…………………………………… 36 References………………………………………….. 39 2 LIST OF FIGURES 1. Figure 1: Erythrocyte Cytoskeleton Schematic……….. 10 2. Figure 2: Map of Duffy (-) Expression in Africa……….. 13 3. Table 1: Invasion Pathways of Plasmodium falciparum 14 4. Figure 3: Map of Overlap of Malaria with Abnormalities 15 5. Figure 4: Erythrocyte Abnormalities……………………. 16 6. Figure 5: Erythrocyte Protein Expression……………… 20 7. Figure 6: Enrichment of Cord Blood……………………. 29 8. Figure 7: Images of Enriched Cord Blood……………... 29 9. Figure 8: Culturing of Parasites…………………………. 31 10. Figure 9: CD71 Expression Through Time…………… 32 11. Figure 10: Glycophorin A Expression on Erythrocytes 33 12. Figure 11: Fy6 Expression on Erythrocytes………….. 33 13. Figure 12: Western Blot of Bound Protein……………. 34 3 Erythrocyte Biology and its Impact on Plasmodium vivax Invasion Abstract by EMILY SCHEETZ Malaria infection caused by Plasmodium species parasites is a world problem and the number of infections and deaths are staggering; 500 million and 1 million per year respectively. Although research on malaria has been extensive, a vaccine remains elusive. Characterization of the human erythrocyte proteins and their expression, and how Plasmodium species parasites exploit these proteins to gain entry into erythrocytes is an aspect of research that cannot be overlooked. In this paper, knowledge of erythrocyte biology, protein expression of erythrocytes, and genetic abnormalities of erythrocytes is combined to better understand the invasion biology of Plasmodium vivax malaria. This research may lay the groundwork for future insight into an in vitro culturing system for P. vivax as well as offer insight into vaccine development. 4 Introduction: The burden of malaria infection has impacted humans throughout the world for hundreds of years. Approximately 3.2 billion people are at risk for malaria [1] and vaccine development efforts have been unsuccessful thus far [2, 3]. Understanding the interaction between Plasmodium parasite species and erythrocytes is one of the most important aspects of vaccine development. The first step in this understanding is the functional role of the cytoskeleton and plasma membrane proteins of the erythrocyte. Expression of particular proteins, mainly the Duffy antigen receptor for chemokines (DARC or Duffy), may determine the invasion capacity of erythrocytes to Plasmodium vivax. Although factors affecting Duffy expression most certainly play a role in the variability of Duffy expression, very little is actually known. Genetic abnormalities of erythrocytes may be factors that affect Duffy expression. The localization of Duffy on the red cell surface may affect invasion of the parasite. Some preliminary data on Duffy expression has been assembled but a much deeper understanding must be reached. Compiling some well understood physical interactions of proteins within the human erythrocyte along with abnormalities and developing data on Duffy expression and parasite invasion, we seek to better understand the invasion pathways utilized by Plasmodium vivax by developing an in vitro culturing model and potentially be more informed about the development of a 5 vaccine against Plasmodium malaria by studying the expression of Duffy on the erythrocyte surface. Chapter 1- Red Blood Cell Biology and Abnormalities The interaction between the cytoskeleton and the plasma membrane of the erythrocyte is vital for the movement of erythrocytes into and out of the capillaries carrying oxygen and removing carbon dioxide from the bloodstream. This movement is also critical for the development of severe malaria and cerebral malaria. Each protein, and the interactions between proteins, contributes to the function or dysfunction of the erythrocyte. Basic knowledge about the constituents involved in erythrocyte function and parasite invasion of erythrocytes lays the ground work for filling in the gaps of scientific understanding. CYTOSKELETAL PROTEINS As in most cells, the cytoskeleton of erythrocytes is quite complex. The cytoskeleton is the network of proteins underlying and interacting with the cell membrane [4]. Multiple protein interactions must take place to keep the network intact and give the cell shape. The cytoskeleton determines the shape, integrity, and elasticity of erythrocytes [5-8]. Of all the cytoskeletal proteins, spectrin is the most abundant making up 75% of the erythrocyte cytoskeleton and is present at 100,000 copies per cell [9]. Because spectrin is the main component of the cytoskeleton it interacts with multiple proteins to form linkages [4]. Spectrin tetramerizes to form filaments which then interact with actin, 4.1, adducin, and 4.9 [10]. Other proteins such as glycophorins C and D and anion-exchanger 1 (band 3) associate with spectrin to 6 form interactions between the plasma membrane and the cytoskeleton [10]. Adaptor proteins such as ankyrin, 4.1, 4.2, and p55 also contribute to binding spectrin and creating the meshwork of the cytoskeleton [10]. Mutations in the spectrin gene lead to hemolytic anemias such as spherocytosis and elliptocytosis [11, 12] and knockouts of spectrin are lethal in nematodes, flies, and mice [13- 15]. RED BLOOD CELL SURFACE PROTEINS Red blood cell surface proteins play various roles in erythrocyte biology. The first important protein is band 3, also known as the anion exchanger. Named for its migration pattern when lysed erythrocytes were run on a gel, band 3 is one of the two most abundant integral proteins of the erythrocyte [16]. With one million copies per cell, band 3 makes up 30% of the total amount of membrane protein [9]. Band 3 is confined to cells of erythroid lineage and kidney cells, and is expressed on mature erythrocytes [17]. Band 3 is involved in membrane anion transport with its C-terminal domain mediating the exchange of chloride and bicarbonate anions, which increases the erythrocyte’s ability to carry CO2 from the tissues [16]. Another of its functions is to help with membrane stability by interacting with the cytoskeleton via Ankyrin-1 [18]. The cytoplasmic domain anchors the sub-membrane protein skeleton with the lipid bilayer by interacting with ankyrin, 4.1, and 4.2 [16]. A second surface protein expressed on erythrocytes is the transferrin receptor, also known as CD71. CD71 is expressed very early in the erythroid lineage maturation [19, 20] The transferrin receptor transports iron bound to 7 transferrin from the extracellular space inside the cell to form hemoglobin [21]. Without CD71, patients experience severe anemia [22]. There is variable expression on the surface of cells because of the varying needs for iron and hemoglobin synthesis [22]. Cells undergoing replication greatly up-regulate the expression of CD71 on their surface [22] and mature erythrocytes express very little CD71 [23]. CD71 is of interest because of its expression on reticulocytes and young cells. This fact is important when providing target cells to in vitro parasite cultures. Counting the number of young and old reticulocytes is done by flow cytometry detecting RNA and CD71 positivity respectively. The glycophorin family of proteins is another group expressed on the surface of erythrocytes. Glycophorins A-C play multiple roles on the surface of erythrocytes. They are the major sialoglycoproteins expressed on the surface [16, 19]. Sialic acids may be ligands for bacteria and viruses as well as parasites. Because the glycophorins give the erythrocyte its negative charge, they may prevent red cell aggregation in circulation and minimize cell-cell intereactions [16, 19]. Glycophorins also contribute to the glycocalyx which plays a role in protection from mechanical damage and microbial attack [16, 19]. Each of the previous proteins, as well as a multitude not described in detail here, interact to create the relationship between the cytoskeleton and plasma membrane. Cytoskeleton and Plasma Membrane Association Spectrin tetramers form a two-dimensional lattice by binding actin and other associated proteins forming a junctional complex. Dissociation and reassociation of the spectrin tetramers allows for the deformabilty of the 8 erythrocyte as it moves through the microvasculature [24]. The interaction between spectrin and the cytoplasmic surface of the plasma membrane controls the erythrocyte shape and elasticity. Spectrin interacts with ankyrin which subsequently
Recommended publications
  • Duffy, and Mnss Group Systems
    Blood Groups – Duffy, and MNSs Group Systems Qun Lu, MD Assistant Professor Division of Transfusion Medicine Department of Pathology and Laboratory Medicine UCLA, School of Medicine Los Angeles, California 2009-03-12 Duffy Blood Group System History . 1950: Mrs. Duffy, a multiply transfused hemophiliac woman, developed an antibody not reacting with the known RBC antigens. Corresponding antigen was named after Mrs. Duffy . 1951: Fyb antibody was described in a woman with 3 pregnancies. 1955: Majority of blacks tested Fy(a-b-) . 1975: Fy(a-b-) RBCs were shown to resist infection by malaria organism Plasmodium vivax. Later: more Duffy antigens (Fy3, Fy4, Fy5, Fy6) were discovered . ISBT: 008 for the Duffy Blood Group Duffy Antigens . Most common: Fya and Fyb. Present at 6 weeks of gestation, well developed at birth – anti- Fy can cause hemolytic disease of newborn . Duffy antigens can be destroyed by enzymes such as ficin, papain, bromelain, chymotrypsin, ZZAP . When compared to Rh or Kell antigens, Duffy antigens are not very immunogenic. So, anti-Fya or anti-Fyb is not common. Fy (a-b-) is not Fy null, but homozygous for Fyb gene, they express Fyb antigen in other tissues, but not on RBCs → only will produce anti-Fya, not anti-Fyb. Fy (a-b-) is negative for Fy6 antigen which is the receptor for P. vivax (Fy6 is + when Fya + or Fyb+) Duffy Antigens . Phenotype Frequencies Chinese Phenotype Whites % Blacks % % Fy (a+b-) 17 9 90.8 Fy (a+b+) 49 1 8.9 Fy (a-b+) 34 22 0.3 Fy (a-b-) rare 68 0 White donor population: Fya: 66% Caucasians, 10% Blacks, 99% Asians Fya – units: 35% Fyb: 83% Caucasians, 23% Blacks, 18.5% Asians Fyb – units: 15% Fy3: 100% Caucasians, 32% Blacks, 99.9% Asians Duffy Antigens .
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • The Gerbich Blood Group System: a Review
    Review The Gerbich blood group system: a review P.S. Walker and M.E. Reid Antigens in the Gerbich blood group system are expressed on glycoproteins are also known as CD236R, and they attach glycophorin C (GPC) and glycophorin D (GPD), which are both to the RBC membrane through an interaction with protein encoded by a single gene, GYPC. The GYPC gene is located on 4.1R and p55. GPC and GPD contain three domains: an ex- the long arm of chromosome 2, and Gerbich antigens are in- tracellular NH2 domain, a transmembrane domain, and an herited as autosomal dominant traits. There are 11 antigens in intracellular or cytoplasmic COOH domain (Figure 1). GPC the Gerbich blood group system, six of high prevalence (Ge2, Ge3, Ge4, GEPL [Ge10*], GEAT [Ge11*], GETI [Ge12*]) and and GPD are encoded by the same gene, GYPC. When the five of low prevalence (Wb [Ge5], Lsa [Ge6], Ana [Ge7], Dha fi rst AUG initiation codon is used, GPC is encoded, whereas [Ge8], GEIS [Ge9]). GPC and GPD interact with protein 4.1R, when the second AUG is used, GPD is encoded. Thus, GPD contributing stability to the RBC membrane. Reduced lev- is a shorter version of GPC, and the amino acids in GPD els of GPC and GPD are associated with hereditary elliptocy- are identical to those found in GPC but lacking the fi rst 21 tosis, and Gerbich antigens act as receptors for the malarial amino acids at the N-terminal of GPC.9,10 parasite Plasmodium falciparum. Anti-Ge2 and anti-Ge3 have caused hemolytic transfusion reactions, and anti-Ge3 has pro- duced hemolytic disease of the fetus and newborn (HDFN).
    [Show full text]
  • The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring
    cells Review The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring Kamila Puchałowicz * and Monika Ewa Ra´c Department of Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected] Received: 2 July 2020; Accepted: 9 August 2020; Published: 11 August 2020 Abstract: CD36 is a multiligand receptor contributing to glucose and lipid metabolism, immune response, inflammation, thrombosis, and fibrosis. A wide range of tissue expression includes cells sensitive to metabolic abnormalities associated with metabolic syndrome and diabetes mellitus (DM), such as monocytes and macrophages, epithelial cells, adipocytes, hepatocytes, skeletal and cardiac myocytes, pancreatic β-cells, kidney glomeruli and tubules cells, pericytes and pigment epithelium cells of the retina, and Schwann cells. These features make CD36 an important component of the pathogenesis of DM and its complications, but also a promising target in the treatment of these disorders. The detrimental effects of CD36 signaling are mediated by the uptake of fatty acids and modified lipoproteins, deposition of lipids and their lipotoxicity, alterations in insulin response and the utilization of energy substrates, oxidative stress, inflammation, apoptosis, and fibrosis leading to the progressive, often irreversible organ dysfunction. This review summarizes the extensive knowledge of the contribution of CD36 to DM and its complications, including nephropathy,
    [Show full text]
  • Flow Reagents Single Color Antibodies CD Chart
    CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n
    [Show full text]
  • Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease
    Molecular Neurobiology (2019) 56:5009–5024 https://doi.org/10.1007/s12035-018-1421-1 Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease Anna Bartoletti-Stella1 & Patrizia Corrado2 & Nicola Mometto2 & Simone Baiardi2 & Pascal F. Durrenberger3 & Thomas Arzberger4,5 & Richard Reynolds6 & Hans Kretzschmar5 & Sabina Capellari1,2 & Piero Parchi1,7 Received: 18 July 2018 /Accepted: 1 November 2018 /Published online: 16 November 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Functional genomics applied to the study of RNA expression profiles identified several abnormal molecular processes in experimental prion disease. However, only a few similar studies have been carried out to date in a naturally occurring human prion disease. To better characterize the transcriptional cascades associated with sporadic Creutzfeldt-Jakob disease (sCJD), the most common human prion disease, we investigated the global gene expression profile in samples from the frontal cortex of 10 patients with sCJD and 10 non-neurological controls by microarray analysis. The comparison identified 333 highly differentially expressed genes (hDEGs) in sCJD. Functional enrichment Gene Ontology analysis revealed that hDEGs were mainly associated with synaptic transmission, including GABA (q value = 0.049) and glutamate (q value = 0.005) signaling, and the immune/ inflammatory response. Furthermore, the analysis of cellular components performed on hDEGs showed a compromised regu- lation of vesicle-mediated transport with mainly up-regulated genes related to the endosome (q value = 0.01), lysosome (q value = 0.04), and extracellular exosome (q value < 0.01). A targeted analysis of the retromer core component VPS35 (vacuolar protein sorting-associated protein 35) showed a down-regulation of gene expression (p value= 0.006) and reduced brain protein levels (p value= 0.002).
    [Show full text]
  • Quantitation of the Number of Molecules of Glycophorins C and D on Normal Red Blood Cells Using Radioiodinatedfab Fragments of Monoclonal Antibodies
    Quantitation of the Number of Molecules of Glycophorins C and D on Normal Red Blood Cells Using RadioiodinatedFab Fragments of Monoclonal Antibodies By Jon Smythe, Brigitte Gardner, andDavid J. Anstee Two rat monoclonal antibodies (BRAC 1 and BRAC 1 1 ) cytes. Fabfragments of BRAC 1 1 and ERIC 10 gave values have been produced. BRAC 1 recognizes an epitope com- of 143,000 molecules GPC per red blood cell (RBC). Fab mon to the human erythrocyte membrane glycoproteins fragments of BRAC1 gave 225,000 molecules of GPC and glycophorin C (GPC) and glycophorin D (GPD). BRAC 11 GPD per RBC. These results indicate that GPC and GPD is specific for GPC. Fabfragments of these antibodies and together are sufficiently abundantto provide membrane at- BRlC 10, a murine monoclonal anti-GPC,were radioiodin- tachment sites for all ofthe protein 4.1 in normal RBCs. ated and used in quantitative binding assays to measure 0 1994 by The American Societyof Hematology. the number of GPC and GPD molecules on normal erythro- HE SHAPE AND deformability of the mature human (200,000)" and those reported for GPC (50,000).7 This nu- Downloaded from http://ashpublications.org/blood/article-pdf/83/6/1668/612763/1668.pdf by guest on 24 September 2021 T erythrocyte is controlled by a flexible two-dimensional merical differencehas led to the suggestion that a significant lattice of proteins, which together comprise the membrane proportion of protein 4.1 in normal erythrocyte membranes skeleton.' The major components of the skeleton are spec- must be bound to sites other than GPC and GPD.3 The trin, actin, ankyrin, and protein 4.1.
    [Show full text]
  • CD Markers Are Routinely Used for the Immunophenotyping of Cells
    ptglab.com 1 CD MARKER ANTIBODIES www.ptglab.com Introduction The cluster of differentiation (abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules. So-called CD markers are routinely used for the immunophenotyping of cells. Despite this use, they are not limited to roles in the immune system and perform a variety of roles in cell differentiation, adhesion, migration, blood clotting, gamete fertilization, amino acid transport and apoptosis, among many others. As such, Proteintech’s mini catalog featuring its antibodies targeting CD markers is applicable to a wide range of research disciplines. PRODUCT FOCUS PECAM1 Platelet endothelial cell adhesion of blood vessels – making up a large portion molecule-1 (PECAM1), also known as cluster of its intracellular junctions. PECAM-1 is also CD Number of differentiation 31 (CD31), is a member of present on the surface of hematopoietic the immunoglobulin gene superfamily of cell cells and immune cells including platelets, CD31 adhesion molecules. It is highly expressed monocytes, neutrophils, natural killer cells, on the surface of the endothelium – the thin megakaryocytes and some types of T-cell. Catalog Number layer of endothelial cells lining the interior 11256-1-AP Type Rabbit Polyclonal Applications ELISA, FC, IF, IHC, IP, WB 16 Publications Immunohistochemical of paraffin-embedded Figure 1: Immunofluorescence staining human hepatocirrhosis using PECAM1, CD31 of PECAM1 (11256-1-AP), Alexa 488 goat antibody (11265-1-AP) at a dilution of 1:50 anti-rabbit (green), and smooth muscle KD/KO Validated (40x objective). alpha-actin (red), courtesy of Nicola Smart. PECAM1: Customer Testimonial Nicola Smart, a cardiovascular researcher “As you can see [the immunostaining] is and a group leader at the University of extremely clean and specific [and] displays Oxford, has said of the PECAM1 antibody strong intercellular junction expression, (11265-1-AP) that it “worked beautifully as expected for a cell adhesion molecule.” on every occasion I’ve tried it.” Proteintech thanks Dr.
    [Show full text]
  • In Vitro Selection for Adhesion of Plasmodium Falciparum-Infected Erythrocytes to ABO Antigens Does Not Affect Pfemp1 and RIFIN
    www.nature.com/scientificreports OPEN In vitro selection for adhesion of Plasmodium falciparum‑infected erythrocytes to ABO antigens does not afect PfEMP1 and RIFIN expression William van der Puije1,2, Christian W. Wang 4, Srinidhi Sudharson 2, Casper Hempel 2, Rebecca W. Olsen 4, Nanna Dalgaard 4, Michael F. Ofori 1, Lars Hviid 3,4, Jørgen A. L. Kurtzhals 2,4 & Trine Staalsoe 2,4* Plasmodium falciparum causes the most severe form of malaria in humans. The adhesion of the infected erythrocytes (IEs) to endothelial receptors (sequestration) and to uninfected erythrocytes (rosetting) are considered major elements in the pathogenesis of the disease. Both sequestration and rosetting appear to involve particular members of several IE variant surface antigens (VSAs) as ligands, interacting with multiple vascular host receptors, including the ABO blood group antigens. In this study, we subjected genetically distinct P. falciparum parasites to in vitro selection for increased IE adhesion to ABO antigens in the absence of potentially confounding receptors. The selection resulted in IEs that adhered stronger to pure ABO antigens, to erythrocytes, and to various human cell lines than their unselected counterparts. However, selection did not result in marked qualitative changes in transcript levels of the genes encoding the best-described VSA families, PfEMP1 and RIFIN. Rather, overall transcription of both gene families tended to decline following selection. Furthermore, selection-induced increases in the adhesion to ABO occurred in the absence of marked changes in immune IgG recognition of IE surface antigens, generally assumed to target mainly VSAs. Our study sheds new light on our understanding of the processes and molecules involved in IE sequestration and rosetting.
    [Show full text]
  • Strain-Specific Innate Immune Signaling Pathways Determine
    Strain-specific innate immune signaling pathways PNAS PLUS determine malaria parasitemia dynamics and host mortality Jian Wua, Linjie Tianb,1, Xiao Yuc,d,1, Sittiporn Pattaradilokrata,e, Jian Lia,f, Mingjun Wangc, Weishi Yug, Yanwei Qia,f, Amir E. Zeitunia, Sethu C. Naira, Steve P. Cramptonb, Marlene S. Orandleh, Silvia M. Bollandb, Chen-Feng Qib, Carole A. Longa, Timothy G. Myersi, John E. Coliganb, Rongfu Wangc,2, and Xin-zhuan Sua,2 aLaboratory of Malaria and Vector Research, and bLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; cCenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030; dState Key Laboratory of Biocontrol and Key Laboratory of Gene Engineering of Ministry of Education, Sun Yat-sen University, Guangzhou 510006, People’s Republic of China; eDepartment of Biology, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand; fState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian 361005, People’s Republic of China; gLaboratory of Cancer Prevention, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 21702; and hComparative Medicine Branch, iGenomic Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 Edited by Fidel Zavala, The Johns Hopkins University School of Public Health, Baltimore, MD, and accepted by the Editorial Board December 18, 2013 (received for review September 2, 2013) Malaria infection triggers vigorous host immune responses; how- (TLRs) and scavenger receptors have been implicated in the re- ever, the parasite ligands, host receptors, and the signaling path- sponse to malaria infection and for triggering proinflammatory ways responsible for these reactions remain unknown or responses (4, 8–15); however, other studies indicated that TLR- controversial.
    [Show full text]
  • Anti-Glycophorin C Antibody (ARG41471)
    Product datasheet [email protected] ARG41471 Package: 100 μl anti-Glycophorin C antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes Glycophorin C Tested Reactivity Hu Tested Application FACS, ICC/IF, IHC-P, IP, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name Glycophorin C Antigen Species Human Immunogen Synthetic peptide of Human Glycophorin C. Conjugation Un-conjugated Alternate Names Glycophorin-D; CD236R; GPD; Glycophorin-C; Glycoprotein beta; Glycoconnectin; GPC; PAS-2; CD antigen CD236; GE; CD236; Sialoglycoprotein D; GYPD; PAS-2' Application Instructions Application table Application Dilution FACS 1:50 ICC/IF 1:50 - 1:200 IHC-P 1:50 - 1:200 IP 1:50 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control K562 Calculated Mw 14 kDa Observed Size ~ 39 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.4), 150 mM NaCl, 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide www.arigobio.com 1/2 Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol GYPC Gene Full Name glycophorin C (Gerbich blood group) Background Glycophorin C (GYPC) is an integral membrane glycoprotein.
    [Show full text]
  • Blood Group Antigens As Receptors for Bacteria and Parasites
    Review: blood group antigens as receptors for bacteria and parasites C. LOMAS-FRANCIS Abbreviations: Gal = galactose; Glc = glucose; NeuAc lectins.4 Lectins are a class of proteins of nonimmune = N-acetylneuraminic acid; GlcNAc = N-acetylglu- origin that can combine with sugars rapidly, selective- cosamine; GalNAc = N-acetylgalactosamine; FUC = ly, and, since binding is noncovalent, reversibly. Lectins fucose; Cer = ceramide. are not confined to plants but are widespread through- out nature, and frequently appear on surfaces of cells, An important phase in the initiation of diseases caused where they are strategically positioned to combine by bacterid and parasites is the adhesion of the infectious with complementary sugars on neighboring cells. agent to tissues of the mammalian host. Adhesion is Lectins are exquisitely specific; they can distinguish mediated by specificligand-receptor interactions. Host between different monosaccharides and specifically cell receptors include a number of structures carrying bind to oligosaccharides, detecting subtle differences blood group antigens. A selection of such receptors and in complex carbohydrate structures. the attaching microorganisms, mostly bacteria, are listed Bacterial attachment to epithelial cells and to RBCs in Table 1 and will be reviewed in this article. results from the interaction of host cell receptors with bacterial surface structures known as fimbriae or pili.5 Table 1. Receptors for bacteria and parasites These submicroscopic hair-like appendages are 5 to 10 Receptors Bacteria and parasites nanometers in diameter and several hundreds of Ii Mycoplasmapneumuniae nanometers long. They protrude from the surface of P1, P, andPk P-fimbriated Escherichia coli the bacteria and serve as bacterial-binding factors by AnWj Haemophilus influenzae producing lectin-like adhesins or hemagglutinins.
    [Show full text]